‘We have just received information confirmed by international media that Pfizer will significantly reduce deliveries of the vaccine to Poland and other European countries in the coming weeks’ - said the Chief of the Chancellery. 


‘These deliveries in the future are to be increased and they are to be increased from what the company had previously planned,’ assured the Chief of the Chancellery.


Dworczyk stressed that the government does not have precise information from Pfizer on how much it will cut supplies in the coming weeks.


He recalled that the government secures both doses for those who have already been vaccinated - the first dose goes to the vaccination centre and the second dose goes to the freezer at the Material Reserves Agency to be used as the second dose. 


The Chief of the Chancellery of Prime Minister assured that every person who received the first dose of the vaccine would also receive the second dose. 


‘Every patient who received the first dose of the vaccine in Poland is guaranteed to receive the second dose regardless how Pfizer's supply changes. This situation shows that it was a good decision, a good strategy,’ he said. 


‘Following precise information from Pfizer regarding the restrictions on the production of the vaccine we will make decisions on any changes to the vaccination schedule,’ the Minister added.


Pfizer announced today that it intends to significantly increase the production of its Covid-19 vaccine, resulting in increased availability of the product beginning in late February. In the meantime, however, the volume of supplies to Europe may be lower. 


According to the announcement of Pfizer authorities, the concern will try to increase the number of doses of the vaccine produced this year to 2 billion. This is 700 million more than originally projected. 


Before that happens, however, the size of deliveries from the Puurs plant in Belgium may ‘fluctuate,’ the company said. The reason is that modifications of the factory need to be done, which require additional regulatory approvals.


‘While this will temporarily impact supplies in late January and early February, it will allow for a significant increase in doses available to patients in late February and March,’ Pfizer announced. 


The Norwegian Institute of Public Health was the first to report the reduced supply of Pfizer vaccines on Friday, saying that instead of the expected 43.800 doses it received 36.000. At the same time, the Institute said the delays would not affect the vaccination program because Norway has still enough unused doses in reserve. Most European countries are in a similar situation.